fluorobenzenes has been researched along with Diabetic Neuropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bramwell, S; Ciruela, A; Dixon, AK; Gonzalez, MI; Lee, K; Pinnock, RD | 1 |
| Cameron, N; Cotter, M; Inkster, M; Nangle, M | 1 |
| Cameron, NE; Cotter, MA; Nangle, MR | 1 |
| Orr, JD | 1 |
2 review(s) available for fluorobenzenes and Diabetic Neuropathies
| Article | Year |
|---|---|
Looking to the future: diabetic neuropathy and effects of rosuvastatin on neurovascular function in diabetes models.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neural Conduction; Pyrimidines; Rats; Regional Blood Flow; Rosuvastatin Calcium; Sciatic Nerve; Sulfonamides; Vasodilation | 2003 |
Statins in the spectrum of neurologic disease.
Topics: Alzheimer Disease; Animals; Atherosclerosis; Cardiovascular Diseases; Diabetic Neuropathies; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Multiple Sclerosis; Nervous System Diseases; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Pyrimidines; Reactive Oxygen Species; Rosuvastatin Calcium; Stroke; Sulfonamides | 2008 |
2 other study(ies) available for fluorobenzenes and Diabetic Neuropathies
| Article | Year |
|---|---|
Identification of MEK1 as a novel target for the treatment of neuropathic pain.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Delivery Systems; Fluorobenzenes; Gene Expression Regulation, Enzymologic; Male; MAP Kinase Kinase 1; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Pain Measurement; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley | 2003 |
Effects of rosuvastatin on nitric oxide-dependent function in aorta and corpus cavernosum of diabetic mice: relationship to cholesterol biosynthesis pathway inhibition and lipid lowering.
Topics: Acetylcholine; Animals; Aorta; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electric Stimulation; Erectile Dysfunction; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred C57BL; Nitric Oxide; Penis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Vasodilation; Vasodilator Agents | 2003 |